Pharma News

Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.

Allergan and Paratek Announce Positive Results From Two Phase 3 Trials of Sarecycline

Tuesday, March 28, 2017

Allergan plc a leading global pharmaceutical company and Paratek Pharmaceuticals Inc a biopharmaceutical company focused on the development and commercialization of innovative therapies based upon tetracycline chemistry announced that two Phase tri...

Lilly Announces $850 Million Investment in U.S. Capital Projects in 2017

Monday, March 27, 2017

Eli Lilly and Company announced plans to invest million in its US operations in The companys investments span facilities across its US enterprise including research laboratories manufacturing sites and general and administrative areas The investmen...

Newron Presents Results of Its Phase IIa Study with Evenamide in Patients with Schizophrenia

Monday, March 27, 2017

Newron Pharmaceuticals SpA a biopharmaceutical company focused on the development of novel therapies for patients with diseases of the central nervous system CNS and pain today presented detailed results of a Phase IIa study with its unique sodium ch...

ShangPharma Announces Strategic Corporate Restructuring of Shanghai ChemPartner

Saturday, March 25, 2017

ShangPharma a leading life science partnering organization providing highquality and costeffective drug development and discovery services technology and investment for the pharmaceutical and biotechnology industry announced today the intent for a st...

CHMP provides positive opinion for EU label update for Novo Nordisk's Tresiba®

Saturday, March 25, 2017

Novo Nordisk today announced that the Committee for Medicinal Products for Human Use CHMP under the European Medicines Agency EMA has issued a positive opinion recommending an update of the label for Tresiba insulin degludec to include data from the...

Elbit Imaging Ltd. Announces that an EMA Orphan Drug Designation has been Granted to Gamida Cell

Friday, March 24, 2017

Elbit Imaging Ltd announced that it was informed by Gamida Cell Ltd an indirect associate of the Company that the orphan drug designation which has been granted by the European Medicines Agencys EMA Committee for Orphan Medicinal Products COMP regard...

C4 Therapeutics and Calico Enter Strategic Partnership to Discover Novel Therapeutics

Friday, March 24, 2017

C Therapeutics CT and Calico today announced a fiveyear collaboration to discover develop and commercialize therapies for treating diseases of aging including cancer Under the terms of the agreement the parties will leverage CTs expertise and capa...

BioLineRx Announces Acquisition of Agalimmune Ltd.

Friday, March 24, 2017

BioLineRx Ltd a clinicalstage biopharmaceutical company focused on oncology and immunology announced today that it has acquired Agalimmune Ltd a private UKbased company with an innovative anticancer immunotherapy platform Acquisition consideration co...

Intec Pharma Initiates Phase I Trial of Accordion Pill for Cannabinoid Therapies

Thursday, March 23, 2017

Intec Pharma Ltd a clinical stage biopharmaceutical company focused on developing drugs based on its proprietary Accordion Pill platform technology announces the initiation of a Phase I clinical trial of APCBDTHC its Accordion Pill platform with the...

Moleculin Receives Orphan Drug Designation for Annamycin

Thursday, March 23, 2017

Moleculin Biotech Inc a preclinical pharmaceutical company focused on the development of anticancer drug candidates some of which are based on license agreements with The University of Texas System on behalf of the MD Anderson Cancer Center today ann...